Weigao Group buys back 3.87 million shares in May, cutting issued share base to 4.46 billion

Bulletin Express06-01

Shandong Weigao Group Medical Polymer Company Limited reported that, for the month ended 31 May 2026, it repurchased 3.87 million H-shares on the Hong Kong market, spending an estimated HKD 13.25 million at prices ranging from HKD 3.32 to HKD 3.56 per share.

Authorised capital unchanged • Authorised share capital remained at RMB 457.06 million, comprising 4.52 billion H-shares and 48.30 million non-listed shares, each with a par value of RMB 0.10.

Issued and treasury shares • Issued H-shares (excluding treasury shares) declined to 4.46 billion from 4.47 billion at the end of April. • Treasury shares increased to 57.69 million, or approximately 1.3 % of the total issued share capital. • Total issued shares, inclusive of treasury stock, stayed at 4.52 billion.

Public float The company confirmed that public float met the Main Board’s 25 % minimum requirement as at 31 May 2026.

Repurchase details Nineteen on-market transactions were executed between 4 May and 29 May 2026, with individual deal sizes ranging from 62,000 to 690,000 shares. The weighted average repurchase price stood at roughly HKD 3.43 per share.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment